Literature DB >> 12370832

Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21.

James R Jabbur1, Amy D Tabor, Xiaodong Cheng, Hua Wang, Motonari Uesugi, Guillermina Lozano, Wei Zhang.   

Abstract

Analyses of five wild-type p53 containing cell lines revealed lineage specific differences in phosphorylation of Thr18 after treatment with ionizing (IR) or ultraviolet (UV) radiation. Importantly, Thr18 phosphorylation correlated with induction of the p53 downstream targets p21(Waf1/Cip1) (p21) and Mdm-2, suggesting a transactivation enhancing role. Thr18 phosphorylation has been shown to abolish side-chain hydrogen bonding between Thr18 and Asp21, an interaction necessary for stabilizing alpha-helical conformation within the transactivation domain. Mutagenesis-derived hydrogen bond disruption attenuated the interaction of p53 with the transactivation repressor Mdm-2 but had no direct effect on the interaction of p53 with the basal transcription factor TAF(II)31. However, prior incubation of p53 mutants with Mdm-2 modulated TAF(II)31 interaction with p53, suggesting Mdm-2 blocks the accessibility of p53 to TAF(II)31. Consistently, p53-null cells transfected with hydrogen bond disrupting p53 mutants demonstrated enhanced endogenous p21 expression, whereas p53/Mdm-2-double null cells exhibited no discernible differences in p21 expression. We conclude disruption of intramolecular hydrogen bonding between Thr18 and Asp21 enhances p53 transactivation by modulating Mdm-2 binding, facilitating TAF(II)31 recruitment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370832     DOI: 10.1038/sj.onc.1205856

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage.

Authors:  Armin M Gamper; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

2.  Identification of new p53 acetylation sites in COS-1 cells.

Authors:  Anita Joubel; Robert J Chalkley; Katalin F Medzihradszky; Hubert Hondermarck; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2009-01-19       Impact factor: 5.911

3.  p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop.

Authors:  Alberto Valbuena; Francisco M Vega; Sandra Blanco; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.

Authors:  Chul Won Lee; Josephine C Ferreon; Allan Chris M Ferreon; Munehito Arai; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-20       Impact factor: 11.205

5.  Walleye dermal sarcoma virus rv-cyclin inhibits NF-kappaB-dependent transcription.

Authors:  Sandra L Quackenbush; Ashley Linton; Connie D Brewster; Joel Rovnak
Journal:  Virology       Date:  2009-01-26       Impact factor: 3.616

6.  Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis.

Authors:  Akira Nakamizo; Toshiyuko Amano; Wei Zhang; Xin-Qiao Zhang; Latha Ramdas; Ta-Jen Liu; B Nebiyou Bekele; Tadahisa Shono; Tomio Sasaki; William F Benedict; Raymond Sawaya; Frederick F Lang
Journal:  Neuro Oncol       Date:  2008-04-28       Impact factor: 12.300

Review 7.  Tumour suppression by p53: a role for the DNA damage response?

Authors:  David W Meek
Journal:  Nat Rev Cancer       Date:  2009-09-04       Impact factor: 60.716

8.  Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation.

Authors:  Yunyuan V Wang; Mark Wade; Eetsin Wong; Yao-Cheng Li; Luo Wei Rodewald; Geoffrey M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-17       Impact factor: 11.205

9.  Phosphorylation-induced Conformational Ensemble Switching in an Intrinsically Disordered Cancer/Testis Antigen.

Authors:  Yanan He; Yihong Chen; Steven M Mooney; Krithika Rajagopalan; Ajay Bhargava; Elizabeth Sacho; Keith Weninger; Philip N Bryan; Prakash Kulkarni; John Orban
Journal:  J Biol Chem       Date:  2015-08-04       Impact factor: 5.157

10.  IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.

Authors:  Lynette M Moore; Kristen M Holmes; Sarah M Smith; Ying Wu; Elena Tchougounova; Lene Uhrbom; Raymond Sawaya; Janet M Bruner; Gregory N Fuller; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.